A possible relationship of natural killer T cells with humoral immune response to 23-valent pneumococcal polysaccharide vaccine in clinical settings

被引:7
|
作者
Miyasaka, Tomomitsu
Aoyagi, Tetsuji [2 ]
Uchiyama, Binei [3 ]
Oishi, Kazunori [4 ]
Nakayama, Toshinori [5 ]
Kinjo, Yuki [6 ]
Miyazaki, Yoshitsugu [6 ]
Kunishima, Hiroyuki [2 ]
Hirakata, Yoichi [2 ]
Kaku, Mitsuo [2 ]
Kawakami, Kazuyoshi [1 ]
机构
[1] Tohoku Univ, Grad Sch Med, Dept Med Microbiol Mycol & Immunol, Aoba Ku, Sendai, Miyagi 9808575, Japan
[2] Tohoku Univ, Grad Sch Med, Dept Infect Control & Lab Diagnost, Sendai, Miyagi 9808575, Japan
[3] Katta Gen Hosp, Div Resp Dis, Shiroishi, Miyagi, Japan
[4] Osaka Univ, Microbial Dis Res Inst, Dept Special Pathogens, Lab Clin Res Infect Dis, Suita, Osaka 565, Japan
[5] Chiba Univ, Grad Sch Med, Dept Med Immunol, Chiba, Japan
[6] Natl Inst Infect Dis, Dept Chemotherapy & Mycoses, Tokyo, Japan
关键词
Pneumococcal polysaccharide vaccine; Antibody production; NKT cells; CD1D-RESTRICTED NKT CELLS; STREPTOCOCCUS-PNEUMONIAE; PANDEMIC INFLUENZA; BACTEREMIA; ACTIVATION; INDUCTION; ANTIGENS; ANTIBODY; SUBSETS; MODEL;
D O I
10.1016/j.vaccine.2012.03.007
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Pneumococcal polysaccharide vaccine (PPV), a type-2 thymus-independent antigen, induces the activation of B cells by directly triggering their antigen receptors. Although this type of antigen generally does not undergo class switching from IgM to IgG, PPV has been known to induce IgG2 in vaccinated subjects, which suggests the possible involvement of certain innate immune lymphocytes supporting the activation of B cells and their class switching. In the present study, we addressed the possibility that natural killer (NK) T cells are involved in Ab production caused by PPV. We measured serum levels of IgG against pneumococcal capsular polysaccharides and the numbers of CD4(+), CD8(+) and CD4(-)CD8(-) double negative (ON) invariant NKT (iNKT) cells and CD3(+)CD56(+) NKT cells in the peripheral blood before and after PPV injection. IgG was increased after PPV injection, peaking at 4 weeks after injection in serotypes 6B, 19F and 23F and at 3 months in serotype 14. Low responders, whose serum concentrations of IgG peaked at less than double their original levels, constituted 16%, 13%, 13% and 16% of vaccinated subjects with regard to serotypes 613, 14, 19F and 23F, respectively. A significant positive correlation was detected between an increase in ON iNKT cells and the elevation of anti-serotype 14 IgG; in serotype 19F, DN iNKT cells were more markedly increased in responders than in low responders. These results suggest that DN iNKT cells may be involved in IgG production caused by vaccination against pneumococcal capsular polysaccharides. (c) 2012 Elsevier Ltd. All rights reserved.
引用
收藏
页码:3304 / 3310
页数:7
相关论文
共 50 条
  • [1] Immunogenicity of a 23-valent pneumococcal polysaccharide vaccine in Brazilian elderly
    Simonsen, V
    Brandao, AP
    Brandileone, MCC
    Yara, TI
    Di Fabio, JL
    Lopes, MH
    Jacob, W
    BRAZILIAN JOURNAL OF MEDICAL AND BIOLOGICAL RESEARCH, 2005, 38 (02) : 251 - 260
  • [2] Effect of atorvastatin on humoral immune response to 23-valent pneumococcal polysaccharide vaccination in healthy volunteers: The StatVax randomized clinical trial
    Wildes, Tyler J.
    Grippin, Adam
    Fasanya, Henrietta
    Dyson, Kyle A.
    Brantly, Mark
    VACCINE, 2019, 37 (10) : 1313 - 1324
  • [3] Immunogenicity of A 23-Valent Pneumococcal Polysaccharide Vaccine Among Mexican Children
    Elva Espinosa-Padilla, Sara
    Murata, Chiharu
    Estrada-Parra, Sergio
    Santos-Argumedo, Leopoldo
    Mascarenas, Cesar
    Franco-Paredes, Carlos
    Javier Espinosa-Rosales, Francisco
    ARCHIVES OF MEDICAL RESEARCH, 2012, 43 (05) : 402 - 405
  • [4] Functional immune responses to twelve serotypes after immunization with a 23-valent pneumococcal polysaccharide vaccine in older adults
    Ahn, Jong Gyun
    Kim, Han Wool
    Choi, Hee Jung
    Lee, Jin Hwa
    Kim, Kyung-Hyo
    VACCINE, 2015, 33 (38) : 4770 - 4775
  • [5] Safety and immunogenicity of a single dose 23-valent pneumococcal polysaccharide vaccine in Russian subjects
    Ciprero, Karen
    Zykov, Kirill A.
    Briko, Nikolay I.
    Shekar, Tulin
    Sterling, Tina M.
    Bitieva, Elizaveta
    Stek, Jon E.
    Musey, Luwy
    HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2016, 12 (08) : 2142 - 2147
  • [6] Revaccination with 7-valent pneumococcal conjugate vaccine elicits better serologic response than 23-valent pneumococcal polysaccharide vaccine in HIV-infected adult patients who have undergone primary vaccination with 23-valent pneumococcal polysaccharide vaccine in the era of combination antiretroviral therapy
    Lu, Ching-Lan
    Chang, Sui-Yuan
    Chuang, Yu-Chung
    Liu, Wen-Chun
    Su, Chin-Ting
    Su, Yi-Ching
    Chang, Shu-Fang
    Hung, Chien-Ching
    VACCINE, 2014, 32 (09) : 1031 - 1035
  • [7] Effectiveness and practical uses of 23-valent pneumococcal polysaccharide vaccine in healthy and special populations
    Wang, Yang
    Li, Jingxin
    Wang, Yuxiao
    Gu, Wei
    Zhu, Fengcai
    HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2018, 14 (04) : 1003 - 1012
  • [8] Rethinking results from the Japanese 23-valent pneumococcal polysaccharide vaccine randomized clinical trial
    Gessner, Bradford D.
    Theilacker, Christian
    Jodar, Luis
    VACCINE, 2019, 37 (35) : 4853 - 4857
  • [9] Divergent humoral responses to 23-valent pneumococcal polysaccharide vaccine in critically-ill burn and neurosurgical patients
    Mueller, Scott W.
    Baumgartner, Laura J.
    Maclaren, Rob
    Neumann, Robert
    Wiktor, Arek J.
    Kiser, Tyree H.
    Lindberg, Gordon
    Cava, Luis
    Fish, Douglas N.
    Janoff, Edward N.
    PLOS ONE, 2018, 13 (05):
  • [10] Antibody response to the 23-valent pneumococcal polysaccharide vaccine after conjugate vaccine in patients with chronic lymphocytic leukemia
    Lindstrom, Vesa
    Aittoniemi, Janne
    Salmenniemi, Urpu
    Kayhty, Helena
    Huhtala, Heini
    Sinisalo, Marjatta
    HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2019, 15 (12) : 2910 - 2913